Search

Three Gerstner Sloan Kettering students -- Marta Kovatcheva, Isabel Lam, and Elizabeth Wasmuth -- have been awarded grants that recognize their academic and research excellence.

… Thursday, April 16, 2026 Marta Kovatcheva, a second-year student, has received a Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship (PGS). Since the agency’s inception in 1978, these scholarships have been providing financial support to high-caliber students engaged in

For some patients with metastatic melanoma, a combination of two immunotherapies works better than either drug alone.

… Monday, April 3, 2017 Summary New study data presented at the 2017 AACR Annual Meeting showed that for some patients with metastatic melanoma , a combination of two immunotherapies works better than either drug alone. While some patients with metastatic melanoma benefit greatly from treatment with an

MSK highlights from the recent European Society for Medical Oncology (ESMO) Congress include promising findings on new lung, pancreatic, and colorectal cancer treatments and new insights for how molecular testing can guide personalized medicine.

… Tuesday, October 21, 2025 Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented new studies related to a range of cancer types at the European Society for Medical Oncology (ESMO) Congress 2025, held October 17 to 21 in Berlin.   Highlights included the latest updates on three phase

We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.

… Monday, August 26, 2019 Summary After reaching the end of active cancer treatment, some people may assume that going for follow-up tests would be easy. However, the anxiety around having scans can be overwhelming. Anxiety leading up to doctors’ visits and having scans (sometimes referred to as “scanxiety

A new technology shows great promise for imaging and treating advanced forms of prostate cancer.

… Thursday, July 1, 2021 A transformation is coming for patients with prostate cancer , says Memorial Sloan Kettering medical oncologist Michael Morris . Researchers at MSK have helped pioneer major advances that will enable doctors to pinpoint the location of prostate cancer cells more precisely than

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

… Tuesday, May 14, 2013 Summary Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. This image shows melanocytes – cells that protect the skin from ultraviolet radiation – created in a Memorial Sloan Kettering laboratory using

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

… Thursday, July 10, 2025 Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer metastasis remains a stubborn threat. Metastasis is the name for cancer that has spread

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.

… Tuesday, September 8, 2015 Summary Memorial Sloan Kettering is pioneering the use of a noninvasive scanning technique that has the power to reveal whether a tumor is responding to a treatment within just a few days after a patient has started a regimen. This new platform from General Electric Healthcare

Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.

… Tuesday, October 9, 2018 Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols. Abbreviated breast MRI provides high diagnostic accuracy with

Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.

… Monday, June 30, 2025 Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute. Harrington Discovery Institute Scholar-Innovator Awards support the development